Europe Enteral Feeding Formulas Market Size, Share & Industry Trends Analysis Report By End User, By Application (Oncology, Neurological Disorders, Gastrointestinal Diseases, Diabetes), By Stage, By Product, By Country and Growth Forecast, 2022 - 2028

Europe Enteral Feeding Formulas Market Size, Share & Industry Trends Analysis Report By End User, By Application (Oncology, Neurological Disorders, Gastrointestinal Diseases, Diabetes), By Stage, By Product, By Country and Growth Forecast, 2022 - 2028

The Europe Enteral Feeding Formulas Market would witness market growth of 8.1% CAGR during the forecast period (2022-2028).

These nutrients include carbohydrates (40–60% of total energy demands), protein (14–20% of total energy needs), fat (15–30% of total energy needs), and fiber. For patients with an enteral feeding indication, a variety of parameters, including caloric density, osmolarity and osmolality, delivery channel, source and complexity of nutrients, and disease, are taken into account. The patient's daily calorie requirements are considered while determining the enteral feeding formula's caloric density. Less water is present in enteral diets with increased energy density.

The availability of vitamins and minerals varies depending on the individual demands of the patients and their ailment. Even though the formulation as a whole meets the values required by the Recommended Dietary Allowance, the caretakers and care providers should assess the indication of extra micronutrient supplementation (RDA).

The elderly population in Europe is steadily growing, which has also led to an increase in chronic diseases there. There are a variety of effects of the EU-27's aging population (those 85 years of age or older). Given that elderly individuals tend to use proportionately more social services than younger people, one of the primary areas of concern for the relevant authority is the cost of providing adequate health and long-term care.

Additionally, the number of elderly people with neurological disorders that impair swallowing, such as multiple sclerosis, stroke, and dementia, is rising. Therefore, the issue of nutrition insufficiency among these diagnosed populations is reduced by the availability of nutritional support in the form of oral nutrition supplements and enteral nutrition feeding tube support.

The Germany market is leading the Europe Enteral Feeding Formulas Market by Country in 2021; thereby, achieving a market value of $561.1 million by 2028. The UK market is expected to witness a CAGR of 7.2% during (2022 - 2028). Additionally, The France market is expected to witness a CAGR of 8.9% during (2022 - 2028).

Based on End User, the market is segmented into Hospitals, Long Term Care facilities, Nursing Homes, Assisted Living Facilities, and Home Care Agencies & Hospices. Based on Application, the market is segmented into Oncology, Neurological Disorders, Gastrointestinal Diseases, Diabetes, and Others. Based on Stage, the market is segmented into Adults and Pediatric. Based on Product, the market is segmented into Standard Formula, Disease specific, Diabetic Formula, Renal Formula, Hepatic Formula, Pulmonary Formula, Peptide-based Formula, Other Disease Specific Formula, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Danone S.A. (Sofina Group), Nestle S.A., Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd., Meiji Holdings Co., Ltd., Reckitt Benckiser Group PLC, Hormel Foods Corporation and Medline Industries, Inc.

Scope of the Study

Market Segments covered in the Report:

By End User

  • Hospitals
  • Long Term Care facilities
  • Nursing Homes
  • Assisted Living Facilities
  • Home Care Agencies & Hospices
By Application
  • Oncology
  • Neurological Disorders
  • Gastrointestinal Diseases
  • Diabetes
  • Others
By Stage
  • Adults
  • Pediatric
By Product
  • Standard Formula
  • Disease specific
  • Diabetic Formula
  • Renal Formula
  • Hepatic Formula
  • Pulmonary Formula
  • Peptide-based Formula
  • Other Disease Specific Formula
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Abbott Laboratories
  • Danone S.A. (Sofina Group)
  • Nestle S.A.
  • Fresenius SE & Co. KGaA
  • B. Braun Melsungen AG
  • Otsuka Pharmaceutical Co., Ltd.
  • Meiji Holdings Co., Ltd.
  • Reckitt Benckiser Group PLC
  • Hormel Foods Corporation
  • Medline Industries, Inc.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Enteral Feeding Formulas Market, by End User
1.4.2 Europe Enteral Feeding Formulas Market, by Application
1.4.3 Europe Enteral Feeding Formulas Market, by Stage
1.4.4 Europe Enteral Feeding Formulas Market, by Product
1.4.5 Europe Enteral Feeding Formulas Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Enteral Feeding Market
Chapter 4. Europe Enteral Feeding Formulas Market by End User
4.1 Europe Hospitals Market by Country
4.2 Europe Long Term Care facilities Market by Country
4.3 Europe Nursing Homes Market by Country
4.4 Europe Assisted Living Facilities Market by Country
4.5 Europe Home Care Agencies & Hospices Market by Country
Chapter 5. Europe Enteral Feeding Formulas Market by Application
5.1 Europe Oncology Market by Country
5.2 Europe Neurological Disorders Market by Country
5.3 Europe Gastrointestinal Diseases Market by Country
5.4 Europe Diabetes Market by Country
5.5 Europe Others Market by Country
Chapter 6. Europe Enteral Feeding Formulas Market by Stage
6.1 Europe Adults Market by Country
6.2 Europe Pediatric Market by Country
Chapter 7. Europe Enteral Feeding Formulas Market by Product
7.1 Europe Standard Formula Market by Country
7.2 Europe Disease specific Market by Country
7.3 Europe Diabetic Formula Market by Country
7.4 Europe Renal Formula Market by Country
7.5 Europe Hepatic Formula Market by Country
7.6 Europe Pulmonary Formula Market by Country
7.7 Europe Peptide-based Formula Market by Country
7.8 Europe Other Disease Specific Formula Market by Country
7.9 Europe Others Market by Country
Chapter 8. Europe Enteral Feeding Formulas Market by Country
8.1 Germany Enteral Feeding Formulas Market
8.1.1 Germany Enteral Feeding Formulas Market by End User
8.1.2 Germany Enteral Feeding Formulas Market by Application
8.1.3 Germany Enteral Feeding Formulas Market by Stage
8.1.4 Germany Enteral Feeding Formulas Market by Product
8.2 UK Enteral Feeding Formulas Market
8.2.1 UK Enteral Feeding Formulas Market by End User
8.2.2 UK Enteral Feeding Formulas Market by Application
8.2.3 UK Enteral Feeding Formulas Market by Stage
8.2.4 UK Enteral Feeding Formulas Market by Product
8.3 France Enteral Feeding Formulas Market
8.3.1 France Enteral Feeding Formulas Market by End User
8.3.2 France Enteral Feeding Formulas Market by Application
8.3.3 France Enteral Feeding Formulas Market by Stage
8.3.4 France Enteral Feeding Formulas Market by Product
8.4 Russia Enteral Feeding Formulas Market
8.4.1 Russia Enteral Feeding Formulas Market by End User
8.4.2 Russia Enteral Feeding Formulas Market by Application
8.4.3 Russia Enteral Feeding Formulas Market by Stage
8.4.4 Russia Enteral Feeding Formulas Market by Product
8.5 Spain Enteral Feeding Formulas Market
8.5.1 Spain Enteral Feeding Formulas Market by End User
8.5.2 Spain Enteral Feeding Formulas Market by Application
8.5.3 Spain Enteral Feeding Formulas Market by Stage
8.5.4 Spain Enteral Feeding Formulas Market by Product
8.6 Italy Enteral Feeding Formulas Market
8.6.1 Italy Enteral Feeding Formulas Market by End User
8.6.2 Italy Enteral Feeding Formulas Market by Application
8.6.3 Italy Enteral Feeding Formulas Market by Stage
8.6.4 Italy Enteral Feeding Formulas Market by Product
8.7 Rest of Europe Enteral Feeding Formulas Market
8.7.1 Rest of Europe Enteral Feeding Formulas Market by End User
8.7.2 Rest of Europe Enteral Feeding Formulas Market by Application
8.7.3 Rest of Europe Enteral Feeding Formulas Market by Stage
8.7.4 Rest of Europe Enteral Feeding Formulas Market by Product
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Product Launches and Product Expansions:
9.1.5.2 Geographical Expansions:
9.1.6 SWOT Analysis
9.2 Danone S.A. (Sofina Group)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Recent strategies and developments:
9.2.3.1 Acquisition and Mergers:
9.3 Nestle S.A.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:
9.4 Fresenius SE & Co. KGaA
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Approvals and Trails:
9.5 B. Braun Melsungen AG
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.6 Otsuka Pharmaceutical Co., Ltd.
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Product Launches and Product Expansions:
9.7 Meiji Holdings Co., Ltd.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.7.4 Research & Development Expense
9.8 Reckitt Benckiser Group PLC
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.9 Hormel Foods Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental Analysis
9.9.4 Research & Development Expenses
9.10. Medline Industries, Inc.
9.10.1 Company Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings